Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome

Clinical and Experimental Rheumatology

Volumn 27, Issue 6, 2009, Pages 914-919

  Solano, Carla ^a   Lamuño, Montserrat ^a   Vargas, Angélica ^a   Amezcua Guerra, Luis M ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Classification criteria; Lupus anticoagulant

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; COMPARATIVE STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREGNANCY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 76649092957     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. WILSON WA, GHARAVI AE, KOIKE T et al.: International Consensus Statement on Preliminary Classification Criteria for Definite Antiphospholipid Syndrome: Report of an International Workshop. Arthritis Rheum 1999; 42: 1309-11.
2. MERONI PL, RONDA N, DE ANGELIS V, GROSSI C, RASCHI E, BORGHI MO: Role of anti-beta2 glycoprotein 1 antibodies in antiphospholipid syndrome: in vitro and in vivo studies. Clin Rev Allergy Immunol 2007; 32:67-74.
3. MIYAKIS S, LOCKSHIN MD, ATSUMI T et al.: International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
4. SINGH JA, SOLOMON DH, DOUGADOS M et al.: Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006; 55: 348-52.
5. POURRAT O, JOLLIT C, GOMBERT JM, BOINOT C, PIERRE F: Clinical relevance of the recent update of the classification criteria for definite antiphospholipid syndrome: an obstetric medicine clinic series of 107 patients. J Thromb Haemost 2006; 4: 2276-7.
6. KAUL M, ERKAN D, SAMMARITANO L, LOCKSHIN MD: Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis 2007; 66: 927-30.
7. SWADZBA J, IWANIEC T, SZCZEKLIK A, MUSIAL J: Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases. J Thromb Haemost 2007; 5: 1883-9.
8. BOBBA RS, JOHNSON SR, DAVIS AM: A review of the Sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised Sapporo criteria add value? J Rheumatol 2007;34: 1522-7.
9. BRANDT JT, TRIPLETT DA, ALVING B, SCHARRER I: Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
10. HARRIS EN: Syndrome of the black swan. Br J Rheumatol 1987; 26: 324-6.
11. CERVERA R: Coronary and valvular syndromes and antiphospholipid antibodies. Thromb Res 2004; 114: 501-7.
12. AMIGO MC, GARCIA-TORRES R, ROBLES M, BOCHICCHIO T, REYES PA: Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-5.
13. GALLI M, DALDOSSI M, BARBUI T: Antiglycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1994; 71: 571-5.
14. AVCIN T, TOPLAK N: Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep 2007; 9: 212-8.
15. SÈNE D, PIETTE JC, CACOUB P: Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev 2008;7: 272-7.
16. SKOURI H, GANDOUZ R, KRAIEM I, HARRABI I, BEN SAID M: Antibodies to anionic phospholipids and cofactors in kala-azar. Comparative study with malaria, toxoplasmosis and "autoimmune diseases". Clin Exp Rheumatol 2008; 26: 894-902.
17. AMITAL H, GOVONI M, MAYA R et al.: Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 2008; 26 (Suppl, 48): S27-32.
18. GALLI M, LUCIANI D, BERTOLINI G, BARBUI T: Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the anti-phospholipid syndrome. Blood 2003; 102: 2717-23.
19. FADEN D, TINCANI A, TANZI P et al.: Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 73: 37-42.
20. LEE EY, LEE CK, LEE TH et al.: Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb Res 2003; 111: 29-32.
21. EBELING F, PETTERSSON T, MUUKKONEN L, VAHTERA E, RASI V: Beta-2-glycoprotein I antibodies in patients with thrombosis. Scand J Clin Lab Invest 2003; 63: 111-8.
22. NASH MJ, CAMILLERI RS, KUNKA S, MACKIE IJ, MACHIN SJ, COHEN H: The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost 2004; 2: 1077-81.